期刊文献+

苯妥英钠诱导大鼠牙龈增生模型的建立 被引量:1

TO ESTABLISH RAT MODELS OF GINGIVAL HYPERPLASIA INDUCED BY PHT
下载PDF
导出
摘要 目的:通过腹腔注射苯妥英钠溶液的方法诱导建立大鼠牙龈增生模型,测量牙龈体积,观察病理学表现,确定诱导大鼠牙龈增生的最佳给药浓度及可靠性,为进一步研究牙龈上皮增生提供实验基础。方法:将60只大鼠随机平均分为对照组(腹腔注射生理盐水1 m L)和实验一、二、三、四组(腹腔注射0、5、25、50、100 mg/m L PHT溶液),连续28d,肉眼观察大鼠牙龈形态改变,取下颌骨标本,测量下前牙牙龈体积,观察牙龈病理表现。结果:100 mg/m L组表现出牙龈增生的大鼠数量最多,牙龈体积变化最为显著。大鼠下前牙牙龈体积组间比较差异显著,且与给药剂量正相关。结论:腹腔注射PHT溶液28d后多数大鼠出现牙龈增生,100 mg/kg组的发病率最高,增生最显著。牙龈增生主要发生于前牙区和下颌第一磨牙区,其组织病理表现与以往研究基本一致。 Objective: To establish rat models of gingival hyperplasia induced by PHT,ensure the best optimum concentration of PHT and reliability through measuring the volume change of gums and observing the pathological changes,in order to provide the experimental basis for the study of gingival epithelial hyperplasia. Methods: 60 SD rats were randomly divided into five groups equally: 0( control group),5 mg / m L,25 mg / m L,50 mg / m L,100 mg / m L injected with PHT. All rats were operated through intraperitoneal injection for 28 days,observed rat morphological change by macroscopic,then sacrificed all the rats for measuring gum volume of under former and observing the pathology of gums through mandibular specimens. Results: 100 mg / m L group showed the largest number of gingival hyperplasia in rats,and the change of gum volume was the most significant. The gum volume of mandibular anterior teeth had significant difference between each group,and positively related to the drug delivery dosage. Conclusion: After intraperitoneal injection of PHT,most gingival hyperplasia in rats appeared in 28 days,the highest rate of gingival hyperplasia happened in the 100 mg / kg group. Gingival hyperplasia mainly happened in the mandibular anterior teeth and mandibular first molar area,its histopathological performance was consistent with previous research.
出处 《内蒙古医科大学学报》 2016年第2期103-108,共6页 Journal of Inner Mongolia Medical University
关键词 苯妥英钠 牙龈增生 大鼠 phenytoin gingival hyperplasia rat
  • 相关文献

参考文献15

  • 1李午丽,赵守亮.药物性牙龈增生与胶原代谢失衡的相关性研究进展[J].牙体牙髓牙周病学杂志,2014,24(11):681-684. 被引量:4
  • 2靳晶,薛静,柴士伟.丙戊酸钠与苯妥英钠治疗癫痫持续状态的系统评价[J].中国现代应用药学,2015,32(1):90-94. 被引量:15
  • 3Hassell TM, Roebuck S, Page RC, et al. Quantitative his- topathologic assessment of developing phenytoin-induced gingivai overgrowth in the cat [ J ]. J Clin Periodontol, 1982 ;9(7) :365-372.
  • 4Assaggaf MA, Kantarci A, Sume SS, et al. Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice[ J]. Am J Patho1,2015 ;185(6) : 1588-1599.
  • 5Li WL, Wu CH, Yang J, et al. Local inflammation alters mmp-2and mmp-9gelatinase expression associated with the severity of nifedipine- induced gingival overgrowth: a rat model study[ J]. Inflammation,2015 ;38(4) : 1517-1528.
  • 6乔建梁,刘补报,张俊晶,孟兴凯.显微镜下大鼠70%肝切除模型的制备[J].内蒙古医科大学学报,2014,36(4):302-305. 被引量:2
  • 7Nassar CA, Nassar PO, Andia DC, et al. The effects of up to 240 days of tacrolimus therapy on the gingival tissues of rats- a morphological evaluation [ J ]. oral Dis, 2008 ; 14 ( 1 ) :67-72.
  • 8Akiyama Y, Mori Y, Nakamura Y, et al. Relationship between phenytoin treatment dose, Duration or age and the severity of drug-induced gingival overgrowth in rats[ J]. J Jpn Soc Disabil Oral Health, 1995 ;16( 8 ) :242-248.
  • 9Fukui N, Kato T, Hayashi M, et al. Drug-induced gingival overgrowth in rats treated with diet containing high-dose phenytoin [ J ]. Jpa Soc Disa6il Oral Health, 2000 ; 21 ( 7 ) : 304-309.
  • 10Vahabi S, Salman BN, Rezazadeh F, et al. Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: an in vitro study [ J ]. J Basic Clin Physiol Pharmacol,2014 ;25 ( 2 ) : 167-173.

二级参考文献34

  • 1Maria-Angeles Aller,Natalia Arias,Isabel Prieto,Salvador Agudo,Carlos Gilsanz,Laureano Lorente,Jorge-Luis Arias,Jaime Arias.A half century (1961-2011) of applying microsurgery to experimental liver research[J].World Journal of Hepatology,2012,4(7):199-208. 被引量:4
  • 2Corra JD, Queiroz-Junior CM, Costa JE , et al. Phenytoin-in- duced gingival overgrowth: a review of the molecular, immune, and inflammatory features [ J ]. ISRN Dent, 2011, 2011 : 497850.
  • 3Subramani T, Rathnavelu V, Alitheen NB, et al. The possible potential therapeutic targets for drug induced gingival overgrowth [ J]. Mediators Inflamm, 2013,2013:639468.
  • 4Nishimura F, Naruishi H, Naruishi K, et al. Cathepsin- L, a key molecule in the pathogenesis of drug-induced and I-cell dis- ease-mediated gingival overgrowth : a study with cathepsin-L deficient mice [ J ]. Am J Pathol, 2002,161 (6) : 2047 - 2052.
  • 5Sapna G, Gokul S, Bagri-Manjrekar K. Matrix metalloproteinas- es and periodontal diseases[ J]. Oral Dis, 2014,20 (6) :538 - 550.
  • 6Chiu HC, Lu YT, Chin YT, et al. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingi- va[J]. J Periodontal Res, 2009, 44(3) :338 -347.
  • 7Liu L, Li C, Cai X, et al. The temporal expression and localiza- tion of extracellular matrix metalloproteinase inducer (EMM- PRIN) during the development of periodontitis in an animal model[ J ]. J Periodontal Res, 2010, 45 (4) :541 - 549.
  • 8El Hajj EC, E1 Hajj MC, Voloshenyuk TG, et al. Alcohol Mod- ulation of Cardiac Matrix metalloproteinases (MMPs) and Tissue Inhibitors of MMPs Favors Collagen Accumulation [ J ]. Alcohol Clin Exp Res, 2014, 38(2) :448 -456.
  • 9Sakagami G, Sato E, Sugita Y, et al. Effects of nifedipine and interleukin-1 a on the expression of collagen, matrix metallopro-teinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts [ J ]. J Periodontal Res, 2006,41 (4) : 266 - 272.
  • 10Kuo PJ, Tu HP, Chin YT, et al. Cyclosporine-A inhibits MMP-2 and-9 activities in the presence of Porphyromonas gingi- valis lipopolysaccharide: an experiment in human gingival fibro- blast and U937 macrophage co-culture [ J ]. J Periodontal Res, 2012,47 (4) :431 -438.

共引文献18

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部